Correlation Analysis of Blood Lipid Level and Thyroid Tumors

Author:

Liu Shuang1,Guo Yuanyuan1,Li Zhijie1,Gong Jun2,Liao Pu1

Affiliation:

1. Chongqing General Hospital

2. University-Town Hospital of Chongqing Medical University

Abstract

Abstract Background: The level of blood lipids has been found to reflect the occurrence and development of tumors to a certain extent. This article explores the correlation between blood lipid levels and thyroid tumors. Methods: A total of 915 patients with thyroid tumors were enrolled in this study and divided into two groups according to the benign and malignant tumors. The total cholesterol (TCHO), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), lipoprotein (a) and other detection indicators before starting treatment were recorded. The comparison between the two groups were evaluated by Mann-Whitney test and Chi-square test. The relationship between the blood lipid level and thyroid tumors were assessed by Spearman correlation analysis , dose-effect analysis and logistic regression methods. Results: Serum TCHO (median 4.85 vs 5,14, p=0.001), HDL-C (median 1.37 vs 1.48, p=0.001), LDL-C (median 2.50 vs 2.68, p=0.006) and lipoprotein (a) (median 111 vs 133, p=0.023) levels of patients with malignant thyroid tumors were significantly lower than those of patients with benign thyroid tumors. The logistic regression models showed that the OR value of HDL-C was 0.493(0.272,0.894), and the P value was 0.02. This suggests that HDL-C is a protective factor. In addition, HDL-C was negatively correlated with lymph node metastasis(p=0.005) and the maximum tumor diameter(p=0.024). Conclusion: Serum lipid level is correlated with the occurrence and development of thyroid tumors to a certain extent, and the level of HDL-C is a protective factor for thyroid tumors.

Publisher

Research Square Platform LLC

Reference24 articles.

1. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach;Jung CK;Endocrinol Metab (Seoul),2022

2. Burden of Thyroid Cancer From 1990 to 2019 and Projections of Incidence and Mortality Until 2039 in China: Findings From Global Burden of Disease Study;Cheng F;Front Endocrinol (Lausanne),2021

3. Quality control index for standardized diagnosis and treatment of thyroid cancer in China. (2022 edition). Zhonghua Zhong Liu Za Zhi 2022;44(9):902–907, 10.3760/cma.j.cn112152-20220707-00477.

4. Contemporary Thyroid Nodule Evaluation and Management;Grani G;J Clin Endocrinol Metab,2020

5. Chen DW, Lang BHH, McLeod DSA, et al. Thyroid cancer Lancet. 2023;401(10387):1531–44. 10.1016/s0140-6736(23)00020-x.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3